SG HealthCare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Revenue	16,478	16,105	27,779	25,499
Other Revenue	-	-	-0	-0
Revenue	16,478	16,105	27,779	25,499
Revenue Growth (YoY)	-11.90%	-42.02%	8.94%	-
Cost of Revenue	12,320	10,968	20,687	19,344
Gross Profit	4,158	5,136	7,091	6,155
Selling, General & Admin	4,019	4,289	3,852	3,672
Research & Development	786.57	681.85	557.34	517.39
Amortization of Goodwill & Intangibles	0.41	1.62	1.46	1.45
Other Operating Expenses	5.17	4.07	5.93	8.74
Operating Expenses	5,852	5,809	4,844	4,396
Operating Income	-1,693	-673.1	2,248	1,759
Interest Expense	-409.42	-483.91	-1,017	-1,509
Interest & Investment Income	177.77	135.66	122.96	56.79
Earnings From Equity Investments	-	-	-0.91	-1.15
Currency Exchange Gain (Loss)	457.94	936.02	129.77	67.54
Other Non Operating Income (Expenses)	-3,199	-3,475	716.86	-641.05
EBT Excluding Unusual Items	-4,666	-3,561	2,199	-267.75
Gain (Loss) on Sale of Investments	23.19	-10.27	-	-1.36
Gain (Loss) on Sale of Assets	-75.54	-71.42	-	1.53
Asset Writedown	-25.08	-13	-84.13	-
Pretax Income	-4,743	-3,655	2,115	-267.57
Income Tax Expense	-537.28	-122.31	339.19	183.37
Earnings From Continuing Operations	-4,206	-3,533	1,776	-450.94
Minority Interest in Earnings	-43.67	-14.42	-9.22	-
Net Income	-4,250	-3,547	1,767	-450.94
Net Income to Common	-4,250	-3,547	1,767	-450.94
Shares Outstanding (Basic)	9	9	8	6
Shares Outstanding (Diluted)	9	9	8	6
Shares Change (YoY)	-21.66%	18.86%	28.47%	-
EPS (Basic)	-493.40	-386.39	228.74	-75.00
EPS (Diluted)	-493.40	-386.39	228.74	-75.00
Free Cash Flow	-4,784	-2,936	-432.66	-1,946
Free Cash Flow Per Share	-555.40	-319.76	-56.01	-323.67
Gross Margin	25.24%	31.89%	25.53%	24.14%
Operating Margin	-10.28%	-4.18%	8.09%	6.90%
Profit Margin	-25.79%	-22.03%	6.36%	-1.77%
Free Cash Flow Margin	-29.03%	-18.23%	-1.56%	-7.63%
EBITDA	-1,275	-303.9	2,552	2,055
EBITDA Margin	-7.74%	-1.89%	9.19%	8.06%
D&A For EBITDA	418.26	369.2	303.78	295.63
EBIT	-1,693	-673.1	2,248	1,759
EBIT Margin	-10.28%	-4.18%	8.09%	6.90%
Effective Tax Rate	-	-	16.04%	-
Advertising Expenses	-	188.65	267.8	354.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.